Tiziana Life Sciences PLC TIZAF:OTCPK

RT Quote | Exchange | USD
Last | 02/10/21 EST
1.95UNCH (UNCH)
52 week range
1.05 - 3.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.95
  • 52 Week High3.00
  • 52 Week High Date02/02/21
  • 52 Week Low1.05
  • 52 Week Low Date05/15/20
  • Market Cap243.16M
  • Shares Out165.81M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.06
  • P/E (TTM)-31.06
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Tiziana Life Sciences PLC News

There is no recent news for this security.

Latest TIZAF News From Our Partners

QUOTE FINDER

Profile

MORE
Tiziana Life Sciences PLC is a clinical-stage biotechnology company. The Company is focused on targeted drugs to treat diseases in oncology and immunology, with a focus on metastatic cancers. Its lead product candidates include Milciclib (TZLS-201) and Foralumab (TZLS-401). Its products also include Anti IK-6r (TZLS-501) and StemPrintER. The Company is focused on its lead compound, Milciclib, a molecule which blocks the action of specific enzymes called cyclin-dependent...
Gabriele Cerrone
Chairman
Shailubhai Kunwar
Chief Executive Officer
James Tripp
Chief Operating Officer
Tiziano Lazzaretti
Chief Financial Officer
Address
3rd Fl, 11/12 St. James's Square
London
SW1Y 4LB
United Kingdom